Published in BMJ on July 05, 2012
Internet testing for Chlamydia trachomatis in England, 2006 to 2010. BMC Public Health (2012) 1.18
Young men's views toward the barriers and facilitators of Internet-based Chlamydia trachomatis screening: qualitative study. J Med Internet Res (2013) 1.05
Uptake and population-level impact of expedited partner therapy (EPT) on Chlamydia trachomatis and Neisseria gonorrhoeae: the Washington State community-level randomized trial of EPT. PLoS Med (2015) 0.94
The views of general practitioners and practice nurses towards the barriers and facilitators of proactive, internet-based chlamydia screening for reaching young heterosexual men. BMC Fam Pract (2014) 0.86
Chlamydia trachomatis load in population-based screening and STI-clinics: implications for screening policy. PLoS One (2015) 0.85
Get Checked… Where? The Development of a Comprehensive, Integrated Internet-Based Testing Program for Sexually Transmitted and Blood-Borne Infections in British Columbia, Canada. JMIR Res Protoc (2016) 0.85
Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey. Eur J Public Health (2015) 0.84
Systematic screening with information and home sampling for genital Chlamydia trachomatis infections in young men and women in Norway: a randomized controlled trial. BMC Infect Dis (2013) 0.84
C. trachomatis Pgp3 antibody prevalence in young women in England, 1993-2010. PLoS One (2013) 0.84
Stepped wedge cluster randomised trials: a review of the statistical methodology used and available. BMC Med Res Methodol (2016) 0.83
The influence of two different invitation letters on Chlamydia testing participation: randomized controlled trial. J Med Internet Res (2014) 0.83
Home-based chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes. BMC Public Health (2013) 0.83
Non-participation in chlamydia screening in The Netherlands: determinants associated with young people's intention to participate in chlamydia screening. BMC Public Health (2013) 0.82
Comparison of STI-related consultations among ethnic groups in the Netherlands: an epidemiologic study using electronic records from general practices. BMC Fam Pract (2015) 0.82
Effects of population based screening for Chlamydia infections in the Netherlands limited by declining participation rates. PLoS One (2013) 0.80
Chlamydia trachomatis prevalence and chlamydial/HPV co-infection among HPV-unvaccinated young Italian females with normal cytology. Hum Vaccin Immunother (2014) 0.78
Design of the FemCure study: prospective multicentre study on the transmission of genital and extra-genital Chlamydia trachomatis infections in women receiving routine care. BMC Infect Dis (2016) 0.77
Socioeconomic factors and other sources of variation in the prevalence of genital chlamydia infections: A systematic review and meta-analysis. BMC Public Health (2015) 0.77
Higher Chlamydia trachomatis prevalence in ethnic minorities does not always reflect higher sexual risk behaviour. PLoS One (2013) 0.76
Screening for Chlamydia trachomatis. BMJ (2012) 0.75
Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014. Euro Surveill (2017) 0.75
Analysis of cluster randomised stepped wedge trials with repeated cross-sectional samples. Trials (2017) 0.75
The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model. PLoS One (2015) 0.75
Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection. Cancer Med (2015) 0.75
A Web-Based Respondent Driven Sampling Pilot Targeting Young People at Risk for Chlamydia Trachomatis in Social and Sexual Networks with Testing: A Use Evaluation. Int J Environ Res Public Health (2015) 0.75
Predictors of Chlamydia Trachomatis testing: perceived norms, susceptibility, changes in partner status, and underestimation of own risk. BMC Public Health (2016) 0.75
The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women. BMC Infect Dis (2017) 0.75
The added value of chlamydia screening between 2008-2010 in reaching young people in addition to chlamydia testing in regular care; an observational study. BMC Infect Dis (2014) 0.75
WHOLE-GENOME SEQUENCING AND VARIANT ANALYSIS OF HPV16 INFECTIONS. J Virol (2017) 0.75
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med (1996) 11.91
Effectiveness of chlamydia screening: systematic review. Int J Epidemiol (2008) 3.00
Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis (1993) 2.58
Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect (2005) 2.53
Methods in health service research. Evaluation of health interventions at area and organisation level. BMJ (1999) 2.48
Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis (2000) 2.40
Screening programmes for chlamydial infection: when will we ever learn? BMJ (2007) 2.37
Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess (2007) 2.23
Internet-based screening for Chlamydia trachomatis to reach non-clinic populations with mailed self-administered vaginal swabs. Sex Transm Dis (2006) 2.20
Can e-technology through the Internet be used as a new tool to address the Chlamydia trachomatis epidemic by home sampling and vaginal swabs? Sex Transm Dis (2009) 2.09
Who has sex with whom? Characteristics of heterosexual partnerships reported in a national probability survey and implications for STI risk. Int J Epidemiol (2008) 2.06
Modelling the effectiveness of chlamydia screening in England. Sex Transm Infect (2006) 1.95
Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics. BMC Public Health (2008) 1.88
Internet-based screening for sexually transmitted infections to reach nonclinic populations in the community: risk factors for infection in men. Sex Transm Dis (2010) 1.72
Who is being tested by the English National Chlamydia Screening Programme? A comparison with national probability survey data. Sex Transm Infect (2011) 1.62
A prediction rule for selective screening of Chlamydia trachomatis infection. Sex Transm Infect (2005) 1.61
Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sex Transm Infect (2006) 1.59
Acceptability of the internet-based Chlamydia screening implementation in the Netherlands and insights into nonresponse. Sex Transm Dis (2011) 1.47
The impact of a comprehensive chlamydia prevention program in Wisconsin. Fam Plann Perspect (1995) 1.47
Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J Infect Dis (2010) 1.38
Rationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands. BMC Infect Dis (2010) 1.32
A retrospective study of efforts to diagnose infections by Chlamydia trachomatis in a Swedish county. Sex Transm Dis (1992) 1.31
Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis. BMC Infect Dis (2010) 1.21
Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study. Sex Transm Infect (2009) 1.20
Effect of pelvic inflammatory disease on fertility. Venereology (1995) 1.10
Who participates in the Dutch Chlamydia screening? A study on demographic and behavioral correlates of participation and positivity. Sex Transm Dis (2012) 1.10
Prediction of costs, effectiveness, and disease control of a population-based program using home sampling for diagnosis of urogenital Chlamydia trachomatis Infections. Sex Transm Dis (2006) 1.05
Uptake of regular chlamydia testing by U.S. women: a longitudinal study. Am J Prev Med (2010) 1.04
Keeping participants on board: increasing uptake by automated respondent reminders in an Internet-based chlamydia screening in the Netherlands. BMC Public Health (2012) 0.99
Systematic selection of screening participants by risk score in a Chlamydia screening programme is feasible and effective. Sex Transm Infect (2012) 0.95
Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS (2009) 11.62
Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol (2006) 7.39
Effectiveness of interventions to improve screening for syphilis in pregnancy: a systematic review and meta-analysis. Lancet Infect Dis (2011) 4.71
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt) (2008) 4.38
Improved effectiveness of partner notification for patients with sexually transmitted infections: systematic review. BMJ (2007) 4.12
Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med (2011) 4.02
Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis (2010) 3.15
Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis (2004) 2.24
Alarmingly poor performance in Chlamydia trachomatis point-of-care testing. Sex Transm Infect (2010) 2.16
Standardizing the inclusion of indirect medical costs in economic evaluations. Pharmacoeconomics (2011) 2.10
Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med (2008) 2.07
Surveillance systems for sexually transmitted diseases in Switzerland. Sex Transm Dis (2007) 1.99
What should we do about screening for genital chlamydia? Int J Epidemiol (2002) 1.95
The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam. AIDS (2003) 1.93
Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J Infect Dis (2012) 1.90
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival. AIDS (2003) 1.87
Real-time polymerase chain reaction to diagnose lymphogranuloma venereum. Emerg Infect Dis (2005) 1.84
Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men. AIDS (2004) 1.82
Opportunistic and systematic screening for chlamydia: a study of consultations by young adults in general practice. Br J Gen Pract (2006) 1.75
Lack of evidence for the role of human adenovirus-36 in obesity in a European cohort. Obesity (Silver Spring) (2009) 1.70
Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis (2005) 1.68
Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study. Sex Transm Infect (2011) 1.65
Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children. PLoS One (2012) 1.64
The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect (2005) 1.64
Trends in primary care consultations for asthma in Switzerland, 1989-2002. Int J Epidemiol (2005) 1.61
Age-dependent patterns of infection and severity explaining the low impact of 2009 influenza A (H1N1): evidence from serial serologic surveys in the Netherlands. Am J Epidemiol (2011) 1.52
A measles epidemic threshold in a highly vaccinated population. PLoS Med (2005) 1.51
Effect of hemodiafiltration on quality of life over time. Clin J Am Soc Nephrol (2012) 1.50
The cost-utility of haemodiafiltration versus haemodialysis in the Convective Transport Study. Nephrol Dial Transplant (2013) 1.49
Preventive exercises reduced injury-related costs among adult male amateur soccer players: a cluster-randomised trial. J Physiother (2013) 1.48
Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis. PLoS One (2010) 1.47
Acceptability of the internet-based Chlamydia screening implementation in the Netherlands and insights into nonresponse. Sex Transm Dis (2011) 1.47
[Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine]. Ned Tijdschr Geneeskd (2013) 1.39
Trends in sexually transmitted infections in the Netherlands, combining surveillance data from general practices and sexually transmitted infection centers. BMC Fam Pract (2010) 1.38
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5. Value Health (2012) 1.38
Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface (2010) 1.35
Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity. Popul Health Metr (2006) 1.34
Rationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands. BMC Infect Dis (2010) 1.32
Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. Addiction (2009) 1.30
Emergence and spread of Chlamydia trachomatis variant, Sweden. Emerg Infect Dis (2008) 1.30
Can we improve partner notification rates through expedited partner therapy in the UK? Findings from an exploratory trial of Accelerated Partner Therapy (APT). Sex Transm Infect (2011) 1.28
General practitioners' contribution to the management of community-acquired pneumonia in the Netherlands: a retrospective analysis of primary care, hospital, and national mortality databases with individual data linkage. Prim Care Respir J (2013) 1.27
Disability weights for comorbidity and their influence on health-adjusted life expectancy. Popul Health Metr (2006) 1.27
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr (2006) 1.27
Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study. PLoS One (2012) 1.25
Pathogen adaptation under imperfect vaccination: implications for pertussis. Proc Biol Sci (2005) 1.24
Strategies for partner notification for sexually transmitted infections, including HIV. Cochrane Database Syst Rev (2013) 1.24
Stroke presentation and outcome in developing countries: a prospective study in the Gambia. Stroke (2005) 1.24
Timeliness of vaccination and its effects on fraction of vaccinated population. Vaccine (2008) 1.23
High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and women. Sex Transm Dis (2009) 1.22
Towards an integrated approach in surveillance of vector-borne diseases in Europe. Parasit Vectors (2011) 1.21
Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis. BMC Infect Dis (2010) 1.21
Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes. Epidemics (2010) 1.19
Incidence of sexually transmitted diseases and HIV infection in men who have sex with men related to knowledge, perceived susceptibility, and perceived severity of sexually transmitted diseases and HIV infection: Dutch MSM-Cohort Study. Sex Transm Dis (2006) 1.19
Enhanced hygiene measures and norovirus transmission during an outbreak. Emerg Infect Dis (2009) 1.17
Imported malaria in children in industrialized countries, 1992-2002. Emerg Infect Dis (2009) 1.15
Validation of syndromic surveillance for respiratory pathogen activity. Emerg Infect Dis (2008) 1.15
Costs and effects of chlamydial screening: dynamic versus static modeling. Sex Transm Dis (2005) 1.14
Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean? Int J STD AIDS (2003) 1.14
Concurrency is more complex than it seems. AIDS (2010) 1.14
Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting? J Clin Microbiol (2006) 1.14
Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project. Sex Transm Infect (2007) 1.13
Oral human papillomavirus infection in HIV-negative and HIV-infected MSM. AIDS (2013) 1.13
Q fever: single-point source outbreak with high attack rates and massive numbers of undetected infections across an entire region. Clin Infect Dis (2012) 1.12
Transmission of Chlamydia trachomatis through sexual partnerships: a comparison between three individual-based models and empirical data. J R Soc Interface (2011) 1.12
Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio. Health Econ (2007) 1.11
Design of the INTEGRATE study: effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care. BMC Fam Pract (2014) 1.11
Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know? J Infect Dis (2010) 1.10
Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models. PLoS Med (2011) 1.10
Antenatal screening for HIV, hepatitis B and syphilis in the Netherlands is effective. BMC Infect Dis (2011) 1.10
Who participates in the Dutch Chlamydia screening? A study on demographic and behavioral correlates of participation and positivity. Sex Transm Dis (2012) 1.10